Just 2 weeks remain until Europe's leading conference on Pre-Filled Syringes & Injectable Drug Devices takes place in London!

LONDON, UNITED KINGDOM, January 2, 2019 /EINPresswire.com/ --
This year’s event is focusing on the areas of the biggest growth for the market, hitting on the key hot topics in discussions and paralleling the most recent studies in the field.

Here's a run-down of the hot sessions that cannot afford to be missed:

CASE STUDY: REVIEWING CURRENT HURDLES AND THE IMPACT ON FUTURE STRATEGIES IN DEVICE DEVELOPMENT

Presentation form: Cedric Gysel, Health Care Solutions Design Manager, Johnson & Johnson Design
* Current strategies towards device development and the hindrances which arise due to current processes
* Case studies of device development which circumvent current development challenges and how that has an impact on future stages, e.g. manufacturing and distribution
* How studies conducted have led to a revision and improvement of development practices

DRUG / DEVICE PARENTERAL COMBINATION PRODUCTS: AN APPROACH TO DEFINING THE OVERALL DESIGN SPACE

Presentation form: Steve Chamberlain, Device Engineering Manager, GSK
* Understanding the interaction between the prefilled syringe and the autoinjector device
* Executing characterisation studies to build the knowledge space
* Defining a harmonised control strategy to ensure capability of Critical Quality Attributes

PRE-FILLED SYRINGES AND DRUG-DEVICE COMBINATION PRODUCTS (DDC) – A REGULATOR’S PERSPECTIVE

Presentation from: Veronika Ganeva, Biologicals Quality Assessor, MHRA
* Introduction to DDC
* The current regulatory framework in the EU
* Times of change – a look to the future
* Regulatory challenges

OPPORTUNITIES AND CHALLENGES OF IMPLEMENTATION OF PLATFORM COMPONENT FOR BIOLOGIC INJECTABLE DELIVERY

Presentation from: Elise Legendre, Head of Late stage PFS Development, Sanofi
* Why do we need a platform? A standardised approach
* Where does the platform start and stop in the development process? And are all the area impacted?
* What are the challenges for the projects? The team and the documentation?

PANEL: GLASS VS POLYMERS FOR PRIMARY PACKAGING FOR INJECTABLE DRUG DEVICES

Presentations from: James Mellman, Device Manager, Novartis, Suraj Ramachandran, Director, MSD, Anil Busimi, Strategy and Innovation Global Product Manager, SCHOTT
* The regulatory perspective surrounding primary packaging
* Technical standards
* Component integration

Check out the latest agenda, speaker line-up and attendee list on the event website:
www.pre-filled-syringes.com/ein

For those looking to attend, check out the booking options online.

--- ENDS ---

Contact Information:
For media enquiries contact Jinna Sidhu on Tel: +44 (0)20 7827 688 / Email: hsidhu@smi-online.co.uk

Sponsors of Pre-Filled Syringes & Injectable Drug Devices Europe 2019 include:
Eveon, Fruh, Harro Hoefliger, Mitsubishi Gas Chemical, Mikron, Nemera, Nelson labs, Nipro PharmaPackaging, Owen mumford, PHC Corporation, Schott, Zeon, Zwick Testing Machines

About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world's most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

Jinna Sidhu
SMi Group
+1 207-827-6088
email us here